Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-19

FDA Approved: TRINTELLIX — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for vortioxetine (Trintellix) submitted by Takeda Pharmaceuticals America. The approval updates the product labeling…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRINTELLIX (Vortioxetine)

Snippet

SUPPL AP for TRINTELLIX (VORTIOXETINE)